Showing results (2441-2450 of 2,708) with videos related to

Sort By:
Pageof 271
Movement Disorders : Official Journal of the Movement Disorder Society|March 10, 2020
Aromatic L-Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's DiseaseJohn G Nutt, Carolin Curtze, Amie Hiller, et al.
ACS Central Science|May 4, 2018
Mosquito-Derived Anophelin Sulfoproteins Are Potent AntithromboticsEmma E Watson, Xuyu Liu, Robert E Thompson, et al.
American Journal of Human Genetics|December 13, 2002
Comparison of genome screens for two independent cohorts provides replication of suggestive linkage of bone mineral density to 3p21 and 1p36S G Wilson, P W Reed, A Bansal, et al.
The American Journal of Psychiatry|February 4, 2003
Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled studyMurray A Raskind, Elaine R Peskind, Evan D Kanter, et al.
Journal of Immunological Methods|September 15, 1999
A fully human antibody neutralising biologically active human TGFbeta2 for use in therapyJ E Thompson, T J Vaughan, A J Williams, et al.
ACS Infectious Diseases|July 4, 2020
Structure-Interaction Relationship of Polymyxins with the Membrane of Human Kidney Proximal Tubular CellsXukai Jiang, Shuo Zhang, Mohammad A K Azad, et al.
Tobacco Control|October 19, 2012
Support for removal of point-of-purchase tobacco advertising and displays: findings from the International Tobacco Control (ITC) Canada surveyAbraham Brown, Christian Boudreau, Crawford Moodie, et al.
Clinical Trials (London, England)|November 15, 2018
Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell diseaseJames F Casella, Robert J Adams, Donald J Brambilla, et al.
Journal of Hospital Medicine|September 28, 2018
Prospective Randomized Evaluation of Preoperative Angiotensin-Converting Enzyme Inhibition (PREOP-ACEI)Jason F Shiffermiller, Benjamin J Monson, Chad W Vokoun, et al.
Toxicologic Pathology|May 29, 2016
Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug DevelopmentWendy G Halpern, Mehrdad Ameri, Christopher J Bowman, et al.
Pageof 271